fold gene symbol description id change p value Search Results


gsea platform  (Broad Institute Inc)
90
Broad Institute Inc gsea platform
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Gsea Platform, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc08185465-214-16-20?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
gsea platform - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
network and pathway analysis (geps) system  (Genomatix gmbh)
90
Genomatix gmbh network and pathway analysis (geps) system
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Network And Pathway Analysis (Geps) System, supplied by Genomatix gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc06801832-59-31-31?v=Genomatix+gmbh
Average 90 stars, based on 1 article reviews
network and pathway analysis (geps) system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
graphpad software prism  (GraphPad Software Inc)
90
GraphPad Software Inc graphpad software prism
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Graphpad Software Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/bio_rxiv__2024__08__19__608657-242-8-12?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
graphpad software prism - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
chi-square test  (CH Instruments)
90
CH Instruments chi-square test
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc11473381-100-44-10?v=CH+Instruments
Average 90 stars, based on 1 article reviews
chi-square test - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ggplot2 package  (RStudio)
90
RStudio ggplot2 package
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Ggplot2 Package, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc11613908-225-13-18?v=RStudio
Average 90 stars, based on 1 article reviews
ggplot2 package - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
genes with > log2 fold change (cem/wt_btz and cem/btz7)  (CEM Corporation)
90
CEM Corporation genes with > log2 fold change (cem/wt_btz and cem/btz7)
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Genes With > Log2 Fold Change (Cem/Wt Btz And Cem/Btz7), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc05342701__oncotarget___07___74779___s001-5-5-7?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
genes with > log2 fold change (cem/wt_btz and cem/btz7) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
histograms of upregulated genes  (GraphPad Software Inc)
90
GraphPad Software Inc histograms of upregulated genes
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Histograms Of Upregulated Genes, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pm25625591-98-12-21?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
histograms of upregulated genes - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
pasteuria s1  (Pasteuria Bioscience LLC)
90
Pasteuria Bioscience LLC pasteuria s1
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Pasteuria S1, supplied by Pasteuria Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pmc04551569-33-15-14?v=Pasteuria+Bioscience+LLC
Average 90 stars, based on 1 article reviews
pasteuria s1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
control cells  (ATCC)
99
ATCC control cells
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Control Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pm36835256-544-36-48?v=ATCC
Average 99 stars, based on 1 article reviews
control cells - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
exosome marker proteins  (Exosome Diagnostics)
86
Exosome Diagnostics exosome marker proteins
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Exosome Marker Proteins, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pm41634446-169-66-115?v=Exosome+Diagnostics
Average 86 stars, based on 1 article reviews
exosome marker proteins - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
gene condition microarray fold change qrt pcr fold change alkb1 jet a  (ATCC)
93
ATCC gene condition microarray fold change qrt pcr fold change alkb1 jet a
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Gene Condition Microarray Fold Change Qrt Pcr Fold Change Alkb1 Jet A, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/10__1128_slash_aem__03249___16-701-68-79?v=ATCC
Average 93 stars, based on 1 article reviews
gene condition microarray fold change qrt pcr fold change alkb1 jet a - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
geneexpress software system fold change analysis tool  (Gene Logic Inc)
90
Gene Logic Inc geneexpress software system fold change analysis tool
Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) <t>GSEA</t> analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.
Geneexpress Software System Fold Change Analysis Tool, supplied by Gene Logic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fold+gene+symbol+description+id+change+p+value/pm15136764-85-2-1?v=Gene+Logic+Inc
Average 90 stars, based on 1 article reviews
geneexpress software system fold change analysis tool - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) GSEA analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.

Journal: Stem Cell Reports

Article Title: Non-muscle myosin heavy chain 9 maintains intestinal homeostasis by preventing epithelium necroptosis and colitis adenoma formation

doi: 10.1016/j.stemcr.2021.03.027

Figure Lengend Snippet: Myh9 deficiency promotes colitis-related adenoma formation (A) Oncomine analysis shows that the Myh9 mRNA expression is reduced in multiple types of gastrointestinal tumors in the TCGA database. C, no value (22); 1, cecum adenocarcinoma (22); 2, colon adenocarcinoma (101); 3, colon mucinous adenocarcinoma (22); 4, rectal adenocarcinoma (60); 5, rectal mucinous adenocarcinoma (6); 6, rectosigmoid adenocarcinoma (3); 7, rectosigmoid mucinous adenocarcinoma (1). (B) GSEA analysis of the transcriptome showing an enrichment of colorectal adenomas in Myh9 -KO mice. (C) Relative body weight of control and Myh9- KO mice upon AOM/DSS treatment. Body weight was normalized to the first day of TAM injection. The data represent mean ± SD derived from six mice for control group and five mice for Myh9 KO group. (D) Representative colon of control and Myh9 -KO mice after AOM/DSS treatment. Alcian blue staining was to improve observable adenomas in the colon. Right: quantification of adenoma numbers. The data represent mean ± SD derived from five mice per group. ∗ p < 0.05, Student's t test. (E) H&E staining shows the adenoma in colon from control and Myh9 -KO mice after AOM/DSS treatment. Scale bars, 200 μm.

Article Snippet: Gene set enrichment analysis (GSEA) was performed with rank gene based on fold change on the GSEA platform of the Broad Institute ( http://www.broadinstitute.org/gsea/index.jsp ).

Techniques: Expressing, Control, Injection, Derivative Assay, Staining